Serum prolactin level as a predictive factor for abiraterone response in patients with metastatic castration-resistant prostate cancer.

Tao YangYing LiuShuzhen ChenJiale TianXuyou ZhuLong ZhangWei WangYingyi QinJens RichterAseem AnandChengdang XuYongnan ChiChenyang WangCuidong BianDenglong WuZhenfei LiShengsong Huang

Published in: The Prostate (2022)

Serum PRL levels are predictive of response to AA in patients with mCRPC. Serum PRL levels are positively correlated with the volume of metastatic bone disease.

Keyphrases

small cell lung cancer
postmenopausal women
bone regeneration